Related Experiment Video
Updated: Jun 6, 2026
13:58
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
HIV-1 load comparison using four commercial real-time assays
Thomas Bourlet1, Anne Signori-Schmuck, Laurent Roche
1Laboratoire de Virologie, CHU de Saint-Etienne, 42055 Saint-Etienne cedex 02, France. thomas.bourlet@univ-st-etienne.fr
Journal of Clinical Microbiology
|November 12, 2010
Summary
Accurate HIV-1 RNA viral load monitoring is crucial for patient treatment. This study found significant differences in assay performance across HIV-1 subtypes, highlighting risks of misestimation and recommending consistent assay use for reliable patient management.
Area of Science:
- Virology
- Clinical Diagnostics
- Public Health
Background:
- HIV-1 RNA viral load is essential for monitoring disease progression and antiretroviral therapy effectiveness.
- Accurate viral load quantification is critical to prevent misestimation and ensure appropriate patient management.
- The genetic diversity of HIV-1 poses challenges for the performance of automated real-time assays.
Purpose of the Study:
- To comparatively evaluate the performance of four commercial automated real-time HIV-1 RNA assays.
- To assess the ability of these assays to accurately quantify viral load across different HIV-1 genetic subtypes.
- To identify potential discrepancies in viral load measurements that could impact clinical decision-making.
Main Methods:
- A prospective study involving 74 HIV-1-infected patients.
- Blood samples were tested using Abbott m2000 RealTime HIV-1, bioMérieux NucliSens EasyQ HIV-1 v1.2, and Cobas AmpliPrep/Cobas TaqMan (CAP/CTM) v1.0 and v2.0 assays.
- Comparative analysis of assay performance, reliability, and measurement differences across various HIV-1 genotypes (e.g., CRF02_AG, genotype B).
Main Results:
- Significant differences in reliability and performance were observed among the four tested assays (P < 10(-4)).
- Assay performance varied depending on the HIV-1 subtype, with greater disparity noted for CRF02_AG compared to genotype B.
- Discrepancies in viral load measurements were found between different assay combinations.
Conclusions:
- There is a risk of viral load misestimation due to performance differences among automated real-time assays, particularly influenced by HIV-1 genetic diversity.
- The study underscores the importance of using a consistent assay for serial HIV-1 viral load monitoring to ensure reliable patient management.
- Clinical laboratories should be aware of potential assay-specific biases when interpreting viral load results across different HIV-1 subtypes.
